Actionable news
0
All posts from Actionable news
Actionable news in HALO: Halozyme Therapeutics, Inc.,

Benzinga's Top Initiations

Semgroup Corporation NYSE:SEMG, Theravance Biopharma NASDAQ:TBPH - Benzinga's Top Initiations
  • Analysts at Citigroup assumed coverage of SemGroup Corp SEMG with a Neutral rating. The price target for SemGroup is set to $34. SemGroup shares closed at $30.35 on Wednesday.
  • Analysts at Deutsche Bank initiated coverage on Ariad Pharmaceuticals, Inc. ARIA with a Hold rating. The price target for Ariad Pharmaceuticals is set to $9.50. Ariad Pharmaceuticals shares closed at $9.01 on Wednesday.
DateFirmActionFromTo
Nov 2016CitigroupAssumesNeutral
Aug 2016Goldman SachsInitiates Coverage onBuy
Aug 2016UBSMaintainsBuy

© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.